BIONDD® is a breakthrough technology for oral delivery of biologics.
A proprietary technology that replaces injections with oral dosing. Below, the device in Biograil's own words, illustrated with stills from the company's 2024 animation film.

A capsule patients already know how to take
"BIONDD uses a conventional and small, easy-to-swallow capsule designed for efficient oral delivery."
The capsule carries the biologic and the delivery device together.

Released in the stomach
"The capsule dissolves in the stomach and releases a device with a spring-loaded grabbing mechanism."

Into the tissue, then out of the body
"The device safely attaches to the stomach wall, releasing medication into the tissue for systemic distribution."
"After drug delivery, the bio-compostable device passes safely through the GI tract."

Built for biologics
The platform is being developed for oral delivery of biologics, including peptides, antibodies and RNAs. Biograil is at the pre-clinical stage, with Phase 1 preparations funded by the November 2026 round.
→Discuss your compound